Effect of the SARS-CoV-2 Delta-associated G15U mutation on the s2m element dimerization and its interactions with miR-1307-3p

The stem loop 2 motif (s2m), a highly conserved 41-nucleotide hairpin structure in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome, serves as an attractive therapeutic target that may have important roles in the virus life cycle or interactions with the host. However, the conserved s2m in Delta SARS-CoV-2, a previously dominant variant characterized by high infectivity and disease severity, has received relatively less attention than that of the original SARS-CoV-2 virus. The focus of this work is to identify and define the s2m changes between Delta and SARS-CoV-2 and subsequent impact of those changes upon the s2m dimerization and interactions with the host microRNA miR-1307-3p. Bioinformatics analysis of the GISAID database targeting the s2m element reveals a greater than 99% correlation of a single nucleotide mutation at the 15th position (G15U) in Delta SARS-CoV-2. Based on 1H NMR assignments comparing the imino proton resonance region of s2m and the G15U at 19°C, we find that the U15-A29 base pair closes resulting in a stabilization of the upper stem without overall secondary structure deviation. Increased stability of the upper stem did not affect the chaperone activity of the viral N protein, as it was still able to convert the kissing dimers formed by s2m G15U into a stable duplex conformation, consistent with the s2m reference. However, we find that the s2m G15U mutation drastically reduces the binding affinity of the host miR-1307-3p. These findings demonstrate that the observed G15U mutation alters the secondary structure of s2m with subsequent impact on viral binding of host miR-1307-3p, with potential consequences on the immune response.

[1]  I. Rouzina,et al.  Structural domains of SARS-CoV-2 nucleocapsid protein coordinate to compact long nucleic acid substrates , 2022, Nucleic acids research.

[2]  G. Grant,et al.  microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model , 2022, ACS omega.

[3]  J. Evanseck,et al.  Structural, Dynamical, and Entropic Differences between SARS-CoV and SARS-CoV-2 s2m Elements Using Molecular Dynamics Simulations , 2022, ACS physical chemistry Au.

[4]  A. Leitner,et al.  A hybrid structure determination approach to investigate the druggability of the nucleocapsid protein of SARS-CoV-2 , 2022, bioRxiv.

[5]  J. Evanseck,et al.  Bioinformatics analysis of the s2m mutations within the SARS‐CoV‐2 Omicron lineages , 2022, Journal of medical virology.

[6]  Abhishek S. Rao,et al.  MiRNA-SARS-CoV-2 dialogue and prospective anti-COVID-19 therapies , 2022, Life Sciences.

[7]  R. Granek,et al.  Managing an evolving pandemic: Cryptic circulation of the Delta variant during the Omicron rise , 2022, Science of The Total Environment.

[8]  P. Fournier,et al.  A 21L/BA.2-21K/BA.1 “MixOmicron” SARS-CoV-2 hybrid undetected by qPCR that screen for variant in routine diagnosis , 2022, Infection, Genetics and Evolution.

[9]  S. Gharbia,et al.  Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant , 2022, The New England journal of medicine.

[10]  F. Kirchhoff,et al.  Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning? , 2022, Journal of virology.

[11]  Frances E. Muldoon,et al.  Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity , 2022, Nature.

[12]  D. Peaper,et al.  Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons , 2022, Med.

[13]  Robert G. Brinson,et al.  Highly conserved s2m element of SARS-CoV-2 dimerizes via a kissing complex and interacts with host miRNA-1307-3p , 2021, Nucleic acids research.

[14]  Dandan Tian,et al.  The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape , 2021, Frontiers in Immunology.

[15]  E. Campbell,et al.  Structures and functions of coronavirus replication–transcription complexes and their relevance for SARS-CoV-2 drug design , 2021, Nature reviews. Molecular cell biology.

[16]  E. Klein,et al.  Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Infectious Virus Loads Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals , 2021, medRxiv.

[17]  Vineet D. Menachery,et al.  Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.

[18]  C. Lorson,et al.  Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses , 2021, Journal of Autoimmunity.

[19]  Y. Liu,et al.  The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus , 2021, Journal of travel medicine.

[20]  R. Gibbs,et al.  Transmission event of SARS-CoV-2 delta variant reveals multiple vaccine breakthrough infections , 2021, BMC Medicine.

[21]  W. Scott,et al.  Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome , 2021, Journal of virology.

[22]  L. Lipovich,et al.  miRCOVID-19: Potential Targets of Human miRNAs in SARS-CoV-2 for RNA-Based Drug Discovery , 2021, Non-coding RNA.

[23]  Thi H. O. Nguyen,et al.  Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection , 2021, PLoS pathogens.

[24]  K. Machida,et al.  The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection , 2021, Journal of Biological Chemistry.

[25]  A. Elfiky,et al.  SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses , 2020, Frontiers in Pharmacology.

[26]  J. Qiu,et al.  The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region , 2020, Viruses.

[27]  N. Schork,et al.  Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets , 2020, mSphere.

[28]  K. Saxena,et al.  Secondary structure determination of conserved SARS-CoV-2 RNA elements by NMR spectroscopy , 2020, Nucleic acids research.

[29]  Samira Mahmoudi,et al.  Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors , 2020, Informatics in Medicine Unlocked.

[30]  Opeyemi S. Soremekun,et al.  Identification and classification of differentially expressed genes reveal potential molecular signature associated with SARS-CoV-2 infection in lung adenocarcinomal cells , 2020, Informatics in Medicine Unlocked.

[31]  T. Yeh,et al.  Emerging viral mutants in Australia suggest RNA recombination event in the SARS‐CoV‐2 genome , 2020, The Medical journal of Australia.

[32]  G. Grant,et al.  The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities , 2020, Viruses.

[33]  G. Gao,et al.  Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[34]  Qiang Zhou,et al.  Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.

[35]  P. Mehta,et al.  COVID-19: consider cytokine storm syndromes and immunosuppression , 2020, The Lancet.

[36]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[37]  J. Hageman The Coronavirus Disease 2019 (COVID-19). , 2020, Pediatric annals.

[38]  Ibrahim M. Ibrahim,et al.  COVID-19 spike-host cell receptor GRP78 binding site prediction , 2020, Journal of Infection.

[39]  E. Holmes,et al.  A new coronavirus associated with human respiratory disease in China , 2020, Nature.

[40]  C. Peng,et al.  Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation , 2018, Front. Endocrinol..

[41]  S. Bernacchi,et al.  Retroviral RNA Dimerization: From Structure to Functions , 2018, Front. Microbiol..

[42]  Stefan Elbe,et al.  Data, disease and diplomacy: GISAID's innovative contribution to global health , 2017, Global challenges.

[43]  William B. Klimstra,et al.  MicroRNA Regulation of RNA Virus Replication and Pathogenesis , 2016, Trends in Molecular Medicine.

[44]  T. Tengs,et al.  Distribution and Evolutionary History of the Mobile Genetic Element s2m in Coronaviruses , 2016, Diseases.

[45]  D. Bartel,et al.  Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.

[46]  C. Di Primo,et al.  Mutations of the SL2 dimerization sequence of the hepatitis C genome abrogate viral replication , 2015, Cellular and Molecular Life Sciences.

[47]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[48]  H. Shimoda,et al.  Emergence of Pathogenic Coronaviruses in Cats by Homologous Recombination between Feline and Canine Coronaviruses , 2014, PloS one.

[49]  J. Steitz,et al.  Virus Meets Host MicroRNA: the Destroyer, the Booster, the Hijacker , 2014, Molecular and Cellular Biology.

[50]  S. L. Le Grice,et al.  In-gel probing of individual RNA conformers within a mixed population reveals a dimerization structural switch in the HIV-1 leader , 2013, Nucleic acids research.

[51]  T. Tengs,et al.  A mobile genetic element with unknown function found in distantly related viruses , 2013, Virology Journal.

[52]  R. Gorelick,et al.  Molecular determinants of HIV-1 NCp7 chaperone activity in maturation of the HIV-1 dimerization initiation site , 2012, Nucleic acids research.

[53]  S. Lemon,et al.  Stabilization of hepatitis C virus RNA by an Ago2–miR-122 complex , 2012, Proceedings of the National Academy of Sciences.

[54]  B. Cullen,et al.  Viruses, microRNAs, and host interactions. , 2010, Annual review of microbiology.

[55]  S. Lemon,et al.  Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate. , 2010, RNA.

[56]  Jianbo Chen,et al.  Probing the HIV-1 Genomic RNA Trafficking Pathway and Dimerization by Genetic Recombination and Single Virion Analyses , 2009, PLoS pathogens.

[57]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[58]  R. Wartell,et al.  Conversion of stable RNA hairpin to a metastable dimer in frozen solution. , 2007, RNA.

[59]  Jialing Huang,et al.  Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes , 2007, Nature Medicine.

[60]  Ryan Cook,et al.  Hypersusceptibility to vesicular stomatitis virus infection in Dicer1-deficient mice is due to impaired miR24 and miR93 expression. , 2007, Immunity.

[61]  Xianglan Li,et al.  An efficient thermally induced RNA conformational switch as a framework for the functionalization of RNA nanostructures. , 2006, Journal of the American Chemical Society.

[62]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[63]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[64]  D. Haussler,et al.  The Structure of a Rigorously Conserved RNA Element within the SARS Virus Genome , 2004, PLoS biology.

[65]  J. Greatorex The retroviral RNA dimer linkage: different structures may reflect different roles , 2004, Retrovirology.

[66]  M. Mihailescu,et al.  A proton-coupled dynamic conformational switch in the HIV-1 dimerization initiation site kissing complex. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[67]  F. Pedersen,et al.  Efficient replication of full-length murine leukemia viruses modified at the dimer initiation site regions. , 2004, Virology.

[68]  Ben Berkhout,et al.  Dimerization and Template Switching in the 5′ Untranslated Region between Various Subtypes of Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.

[69]  J. Marino,et al.  Mechanism of nucleocapsid protein catalyzed structural isomerization of the dimerization initiation site of HIV-1. , 2002, Biochemistry.

[70]  Ben Berkhout,et al.  In Vitro Evidence That the Untranslated Leader of the HIV-1 Genome Is an RNA Checkpoint That Regulates Multiple Functions through Conformational Changes* , 2002, The Journal of Biological Chemistry.

[71]  F. Pedersen,et al.  Mutations of the Kissing-Loop Dimerization Sequence Influence the Site Specificity of Murine Leukemia Virus Recombination In Vivo , 2000, Journal of Virology.

[72]  C. Ehresmann,et al.  The crystal structure of the dimerization initiation site of genomic HIV-1 RNA reveals an extended duplex with two adenine bulges. , 1999, Structure.

[73]  P. Simmonds,et al.  Mosaic Structure of the Human Immunodeficiency Virus Type 1 Genome Infecting Lymphoid Cells and the Brain: Evidence for Frequent In Vivo Recombination Events in the Evolution of Regional Populations , 1999, Journal of Virology.

[74]  L. Williams,et al.  Melting of a DNA hairpin without hyperchromism. , 1998, Biochemistry.

[75]  B. Roques,et al.  NCp7 Activates HIV-1Lai RNA Dimerization by Converting a Transient Loop-Loop Complex into a Stable Dimer* , 1996, The Journal of Biological Chemistry.

[76]  B. Berkhout,et al.  Role of the DIS hairpin in replication of human immunodeficiency virus type 1 , 1996, Journal of virology.

[77]  T. Vial,et al.  Immune-mediated side-effects of cytokines in humans. , 1995, Toxicology.

[78]  J. Darlix,et al.  Analytical study of rat retrotransposon VL30 RNA dimerization in vitro and packaging in murine leukemia virus. , 1994, Journal of molecular biology.

[79]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[80]  K. Crandall,et al.  The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.

[81]  D. Draper,et al.  Melting studies of RNA unfolding and RNA-ligand interactions. , 1995, Methods in enzymology.